Search

everythinglearnresearchcommunity

for

Search:↓

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Letrozole reduces seizures but not brain damage in mice.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

JAK inhibitors are effective for long-term management of alopecia areata.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

Sgk3 is essential for normal hair follicle growth and maintenance.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Antizyme slows skin tumor growth by reducing cell growth in mice.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.